XML 27 R12.htm IDEA: XBRL DOCUMENT v3.26.1
Note 1 - The Company and Nature of Operations
 12 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Nature of Operations [Text Block]

1. THE COMPANY AND NATURE OF OPERATIONS

 

ImmuCell Corporation (the “Company”, “we”, “us”, “our”) is an animal health biologics company focused on the development, manufacture and commercialization of products intended to improve the survivability, health and long-term performance of neonatal dairy and beef calves. We primarily manufacture and market the First Defense® product line, providing Immediate Immunity™ to prevent scours in newborn dairy and beef calves. Generally, our products are promoted to veterinarians as well as dairy and beef producers by our sales team and then sold through distributors.  Our primary market is North America although we do sell into other select international regions.  Beginning in the early 2000s, we initiated the development of Re-Tain®, our purified Nisin treatment for sub-clinical mastitis in lactating dairy cows. During late 2025, we made the decision to focus on First Defense® and pause further investment in Re-Tain® manufacturing.